Symptoms:
Muscle and joint tension and stiffness
Chronic and widespread pain in muscles and fibrous tissues
Fatigue and physical exhaustion (asthenia)
Anxiety
Sleep and mood disorders (insomnia, melancholy)
AUFIMIL EPB® are orodispersible tablets, an exclusive patented formula (patent pending) designed for patients suffering from musculoskeletal pain.
It originates from the study of an exclusive complex, EPB®, whose composition promotes improved neuromuscular function while being free from the side effects of NSAIDs, which allows for prolonged use.
It does not contain gluten or lactose, making it suitable for vegans.
- Exclusive EPB® Complex: based on Eschscholzia, PEA, and Boswellia.
- Magnesium
- Vitamin B6
Chewable tablets
- Dry extract of Eschscholzia to facilitate physiological nervous relaxation
- Neuromodulatory PEA molecule produced by the body and used when needed for central pain
- Boswellia serrata dry extract of antioxidant boswellic acids to support joint function and relieve local tension
- Magnesium, a mineral that helps reduce tiredness and mental fatigue
The synergetic presence of these natural substances in AUFIMIL EPB® tablets helps restore normal nutritional balance for physiological neuromuscular function. The pharmaceutical technology of AUFIMIL EPB® orally dissolving tablets facilitates the body’s intake of the natural substances of which the product is made.
For daily doses, see the table below. The recommended dosage is one orally dissolving tablet after breakfast and one after dinner for at least 30 days.
30 chewable tablets with a natural orange flavour.
NUTRITIONAL INFORMATION:
*NRV: Nutrient reference values (Reg. EU 1169/2011)
Highlights e target
2milioni
di pazienti con Fibromialgia
1,2milioni
diagnosticati con Fibromialgia
1%
di loro con AUFIMIL EPB
1,5
confezioni per paziente
18.000